Widespread vaccination of adults helps protect unvaccinated children, according to a new Israeli study.
Covid19-Sources
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants | Nature
Moderna to take mRNA flu and HIV vaccines into Phase 1 trials this year
The four most urgent questions about long COVID
The propagation effect of commuting to work in the spatial transmission of COVID-19 | SpringerLink
The Covid‐19 containment effects of public health measures A spatial difference‐in‐differences approach
Flatten the Curve!
Differential enrichment of yeast DNA in SARS-CoV-2 and related genomes supports synthetic origin hypothesis by Andreas Martin Lisewski :: SSRN
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant
Altered Subgenomic RNA Expression in SARS-CoV-2 B.1.1.7 Infections
How a rampant coronavirus variant blunts our immune defences
COVID-19 Data Explorer
The Lab-Leak Theory: Inside the Fight to Uncover COVID-19’s Origins
Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection
Comparisons of all-cause mortality between European countries and regions - Office for National Statistics
Observational Study on 255 Mechanically Ventilated Covid Patients at the Beginning of the USA Pandemic
SARS-CoV-2 study in human gut organoids
Serial intervals observed in SARS-CoV-2 B.1.617.2 variant cases
Uncertain effects of the pandemic on respiratory viruses
(2) Eric Feigl-Ding auf Twitter: "2) We are expecting the #DeltaVariant to continue growing in the US, outpacing all other variants just like it has in India 🇮🇳 and UK 🇬🇧, and become dominant in US by end of July, if not earlier. Here is the prediction track - via @TWenseleers from @GISAID data. https://t.co/VRWL9abxZd" / Twitter
The Fail West
outbreak.info
The World Mortality Dataset: Tracking excess mortality across countries during the COVID-19 pandemic
Scientists begin to unravel the mysteries of the coronavirus and brains
A town and some villages: a simple COVID-19 network model - Mathematics
Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact
Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact
The Lancet auf Twitter: "NEW—Correspondence reports initial analysis of neutralising antibody activity against #SARS-CoV-2 variants of concern B.1.617.2 and B.1.351 elicited by partial or full vaccination with #BNT162b2 (#Pfizer-BioNTech). Read https://t.co/mW69kw1jCh. Figure from appendix. @TheCrick https://t.co/3rTI65ckg7" / Twitter
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection | Nature Medicine
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination